Tesamorelin

Tesamorelin research reference

Tesamorelin is a GHRH analogue that stimulates endogenous growth-hormone secretion. A regulated tesamorelin medicine exists in the United States for a specific indication involving excess abdominal fat in adults with HIV-associated lipodystrophy; that indication should not be extrapolated to other uses.

Research areas

• GHRH-receptor signaling.
• The GH/IGF-1 axis.
• Body-composition research in the specific context of HIV-associated lipodystrophy.

Evidence context

Regulatory evidence applies to a defined indication and formulation. The VELAIA listing is presented as a research and documentation reference only.

For research purposes only. Not intended for human consumption, self-administration or use as a medicine.